Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
Published on: May 31, 2024
The impact of perianal disease in young patients with inflammatory bowel disease
Nathan P Zwintscher1, Puja M Shah, Amit Argawal
1Department of Surgery, Madigan Army Medical Center, Tacoma, WA, 98431, USA.
Insights
Perianal disease in pediatric inflammatory bowel disease (IBD) patients is linked to more complex fistulas, longer hospital stays, and increased surgical interventions. This suggests a more severe disease course in affected children and young adults.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Outcomes Analysis
Background:
- Perianal disease significantly impacts morbidity in patients with inflammatory bowel disease (IBD).
- Understanding the effect of perianal disease on IBD outcomes in pediatric populations is crucial.
Purpose of the Study:
- To determine the impact of perianal disease on IBD outcomes in children, adolescents, and young adults.
- To analyze associations between perianal disease and factors like complex fistulas, growth failure, and surgical interventions.
Main Methods:
- Analysis of 12,465 inpatient admissions for patients ≤20 years old with IBD using the 2009 Kids' Inpatient Database (KID).
- Stratification of patients by ulcerative colitis (UC) or Crohn's disease (CD) diagnosis.
- Definition of perianal disease, complex fistulas, and growth failure using ICD-9 codes, with logistic regression analysis.
Main Results:
- 4.1% of pediatric IBD patients had perianal disease, predominantly in Crohn's disease (CD) cases (94%).
- Perianal disease was associated with higher rates of complex fistulas (OR=3.5) and increased likelihood of any operation (p<0.001).
- Patients with perianal disease experienced longer hospital stays (7.45 vs. 6.16 days) and higher hospital charges (+$5838).
Conclusions:
- Perianal disease in pediatric IBD patients correlates with extended hospital stays, elevated charges, and more operative procedures.
- The findings indicate that perianal disease in pediatric Crohn's disease patients is associated with a more severe disease course, mirroring adult observations.
Background:
Perianal disease is a potentially significant source of morbidity for patients with inflammatory bowel disease (IBD). We sought to identify the impact of perianal disease on IBD outcomes in children, adolescents, and young adults.
Methods:
We studied 12,465 inpatient admissions for patients ≤20 years old with IBD in 2009 using the Kids' Inpatient Database (KID). Patients were stratified by their principal diagnosis of ulcerative colitis (UC) or Crohn's disease (CD). Perianal disease (perianal abscess, anal fissure, or anal fistula), complex fistulas (rectourethral, rectovaginal, or enterovesical), and growth failure were defined by ICD-9 codes. Logistic regression was performed adjusting for CD or UC, gender, age, need for surgical intervention, fistulas, or growth failure.
Results:
Of the 511 (4.1%) patients with perianal disease, 480 had CD (94%, p < 0.001). Girls were less likely to suffer perianal disease (OR = 0.63, CI 0.52-0.76, p < 0.001). Those with perianal disease were more likely to suffer complex fistulas (OR = 3.5, CI 1.98-6.20, p < 0.001) but less likely to suffer enteroenteral fistulas (OR = 0.30, CI 0.15-0.63, p = 0.001) than those without perianal disease. Perianal disease did not increase the incidence of growth failure (p = 0.997) but doubled the likelihood of an operation of any type during admission (p < 0.001). Additionally, patients with perianal disease spent on average 1.29 more days in the hospital (7.45 vs. 6.16 days, p < 0.001) and accrued $5838 extra in hospital charges (p = 0.005).
Conclusions:
Perianal disease in younger patients is associated with a longer length of stay, higher hospital charges, and increased rates of both perineal and abdominal operative procedures. These data support the notion that, similar to adults, the presence of perianal disease in pediatric Crohn's patients is associated with a more severe course.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

